期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (6)
ObjectivesThis study aimed to assess sexual health and quality of life (QoL) in endometrial cancer survivors and the factors influencing these variabl......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (4)
ObjectiveMolecular profiling is developing to inform treatment in endometrial cancer. Using real world evidence, we sought to evaluate frontline immun......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (9)
BackgroundTreatment options for patients with platinum-resistant/refractory ovarian cancers are limited and only marginally effective. The development......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (12)
ObjectiveTo investigate the use and outcomes of adjuvant chemotherapy for patients with advanced-stage low-grade serous ovarian carcinoma following pr......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; ()
The 'Best of ESGO 2023' manuscript comprises a compilation of the best original research presented during the European Society of Gynaecologic Oncolog......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; ()
Objective To determine oncological outcomes and to identify prognostic factors in women aged <45 years with epithelial ovarian cancer.Methods A mul......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; ()
Background Endometrial cancers with more than one molecular feature-POLE mutations (POLEmut), mismatch repair protein deficiency (MMRd), p53 abnormali......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (1)
ObjectivesThis retrospective study aimed to assess the efficiency of consolidation chemotherapy after 6 cycles of neoadjuvant chemotherapy and delayed......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (5)
Objectives Cervical cancer is preventable and caused by persistent infection with oncogenic human papilloma virus (HPV) types. HPV screening is more s......
期刊： INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023; 33 (4)
Objective To evaluate the non-inferiority and safety of simple hysterectomy in early stage (< 2 cm) cervical cancer.Methods This proof-of-concept r......
